Success Commercial but a little weak in R&D - Principal Statistician AstraZeneca Employee Review

3.0
12 Nov 2024
Recommend
CEO approval
Business outlook

Pros

strong pipelines, good future, and successful commercial launch across the world

Cons

not an R&D driven company so statisticians or other functions in development do not have a very good chance to stand out.

Explore other reviews about AstraZeneca

5.0
25 Jun 2026
Recommend
CEO approval
Business outlook

Pros

Good products, great oncology pipeline

Cons

Global leaders moving to US that have limited understanding of US environment

4.0
29 Jun 2026
Anonymous freelancer
Recommend
CEO approval
Business outlook

Pros

Good pay, enjoyable tasks and duties

Cons

Nothing too terrible, management was subpar

See reviews by: Helpful|Rating|Date|All